Aran et al. suggest that CD5L is upregulated in hepatocellular carcinoma and promotes the proliferation and anti-apoptotic response of liver cancer cells by binding to HSPA5 (GRP78) [42]. This evidence concerns the gene CD5L and liver cancer.